Stay updated with breaking news from Biosolution Baltimore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With production nixed at a Baltimore plant—and its shot’s role in the U.S. vaccination scheme uncertain—AstraZeneca may turn to one of its established pandemic manufacturing partners to crank out doses for the feds.
NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has ...
Lawmakers Grill Vaccine Factory Executives About Manufacturing Mistakes at 1:15 pm NPR As Emergent BioSolution's Baltimore factory was throwing away unfinished COVID-19 vaccine doses and struggling to pass muster with the Food and Drug Administration, the company awarded at least $3 million in bonuses to a handful of executives, according to documents released by a congressional subcommittee Wednesday. The House Select Subcommittee on the Coronavirus Crisis grilled executives from Emergent, which was awarded a $628 million contract with the federal government to boost COVID...
Pool / Getty Images As Emergent BioSolution's Baltimore factory was throwing away unfinished COVID-19 vaccine doses and struggling to pass muster with the Food and Drug Administration, the company awarded at least $3 million in bonuses to a handful of executives, according to documents released by a congressional subcommittee Wednesday. The House Select Subcommittee on the Coronavirus Crisis grilled executives from Emergent, which was awarded a $628 million contract with the federal government to boost COVID-19 vaccine manufacturing capacity. The subcommittee released a trove of document...
OTTAWA -- It could be weeks before Health Canada is able to say for sure whether the first delivery of 300,000 Johnson & Johnson COVID-19 vaccine doses can be used due to the ongoing quality control review, according to the agencyâs chief medical adviser. âWe're still getting more information. Just this past week we had additional information from Johnson & Johnson about the quality of those lots, we've got our scientists reviewing that. So we will have more information in the next couple of weeks on that, but it really depends on looking at that data,â said Dr. Supriya S...